T1	Participants 222 250	patients with schizophrenia.
T2	Participants 390 449	individual patient with schizophrenia receiving medication.
T3	Participants 634 651	Western countries
T4	Participants 1174 1489	comparative study involving 104-week oral treatment with 1 of the 3 drugs (aripiprazole, blonanserin, and paliperidone) in patients with schizophrenia aged 20 years or over who required antipsychotic medication or switching of the current medication to others for reasons such as lack of efficacy and intolerability
T5	Participants 1718 1762	The target number of subjects was set at 300
